Zalcitabine (2′-3′-dideoxycytidine, ddC), also called dideoxycytidine, is a
nucleoside analog reverse transcriptase inhibitor (NARTI) sold under the trade ...
Easy to read patient leaflet for zalcitabine. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Jan 30, 2009 ... Learn about the prescription medication Hivid (Zalcitabine), drug uses, dosage,
side effects, drug interactions, warnings, reviews and patient ...
Find patient medical information for zalcitabine oral on WebMD including its uses
, side effects and safety, interactions, pictures, warnings and user ratings.
Zalcitabine is a dideoxynucleoside compound in which the 3'-hydroxy group on
the sugar moiety has been replaced by a hydrogen. This modification prevents ...
Jan 25, 2001 ... Approval. FDA approval of zalcitabine for use in combination with zidovudine in
adults was granted in 1992. Initial approval was based on trial ...
ddC was also known as zalcitabine or dideoxycytidine. ddC was a nucleoside
analog reverse transcriptase inhibitor, or nuke. ddC was approved in 1992 as an
ddC; 2',3'-Dideoxycytidine; Hivid; NSC 606170; Ro 24-2027/000. Zalcitabine is
an analog of pyrimidine derived from deoxycytidine with the replacement of the ...
The triphosphate form of zalcitabine inhibits HIV reverse transcriptase by
competing for incorporation into viral DNA as well as chain termination of the viral
Several methods have been reported for the synthesis of zalcitabine (Horwitz ...
et al., 1996; Henry et al., 1998) have clearly demonstrated that zalcitabine- ...